Pseudomonas aeruginosa, Carbapenem Resistant

TEST NAME Pseudomonas aeruginosa, Carbapenem Resistant
DISEASE/DISORDER Carbapenem Resistant Pseudomonas aeruginosa infection
ALTERNATE NAME(S) CRPA
METHODOLOGY MALDI-TOF, mCIM, PCR, Antimicrobial susceptibility testing
SPECIAL INSTRUCTIONS Isolate submission REQUIRED
ORDERING INFORMATION TDH DLS Requisition:  PH-4182 Clinical Submission Requisition

Specimen Requirements

Patient Preparation
  • None
Specimen Collection
  • Acceptable Specimen Sources/Type(s) for Submission 

-  Culture isolates non-susceptible to imipenem, meropenem, or doripenem and also non-susceptible to ceftazidime or cefepime.

-  Pure isolate on Non-selective media slant (i.e. TSA, Chocolate, Blood) in screw-capped tube
Specimen Labeling
  • Specimen must be labeled with at least two unique patient identifiers and match accompanying PH-4182 Clinical Submission Requisition.
Specimen Processing
  • None
Specimen Storage and Preservation
  • Store specimens at ambient temperature prior to shipment.
Specimen Transportation
  • Ship specimens at ambient temperature.
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
Specimen Acceptability and Rejection
  • Unsatisfactory specimens include, but may not be limited to:

-  Specimens that are mislabeled or with information that does not match                        accompanying requisition

-  Specimens that are broken in transit

-  Specimens that contain mixed culture

  • Specimens received that do not meet the specimen requirements outlined in the Directory of Services or that deviate from the special instructions will not be acceptable for testing.
Testing Location
  • Nashville

This Page Last Updated: June 4, 2024 at 2:24 PM